GlaxoSmithKline CEO Emma Walmsley has reportedly received a pay cut of 14 per cent after the company missed an internal profit target for sales of routine vaccinations against other diseases.
According the pharmaceutical giant’s annual report, Ms Walmsley’s total remuneration for 2020 came in at seven million pounds (€8.2 million).
The cut, according to comments by Non-Executive Director Urs Rohner in the report, partly reflected a missed internal profit target for biopharmaceuticals, mainly due to lockdowns stopping people from receiving routine vaccinations which cut into the CEO’s bonus.
Ms Walmsley was appointed CEO in 2017, and has made great strides in the company’s restructuring efforts, as it works to split its consumer and pharmaceutical businesses.
GlaxoSmithKline has been among the frontrunners in the effort to develop COVID-19 vaccines and treatments, with the company’s offering, which was developed in conjunction with the University of Oxford, having been approved for use in over 50 countries.
Last month, pharmaceutical chiefs came under fire as EU leaders prioritised the acceleration of COVID-19 vaccination rollouts, with pharmaceutical companies being pressed to abide by delivery commitments.
Related
Marina Di Valletta hosts massive 106.7m Black Pearl superyacht
The superyacht has a dancefloor, a movie theatre, underwater lights, a beach club, a gym, and a deck jacuzzi.
‘More than a business leader’: Hamilton Travel pays tribute to Norman Hamilton
Norman Hamilton set up the travel agency Hamilton Travel in 1992.
Christian Cauchi appointed General Manager for CMA CGM Malta Agency
'I am truly grateful to CMA CGM for the trust and confidence placed in me,' he said.
Australian billionaire’s €70m superyacht spotted off Mellieħa
VOLPINI 2 is owned by Australian logistics billionaire Lindsay Fox.
